● Cambridge Technology informed BSE that the board approved the proposed acquisition of R.P. Web Apps Private Limited for Rs. 3 crores. The nature of consideration of the acquisition will be in cash. The group will be able to leverage the association of Appshark Software Inc to grow in IT space in USA.
● The Kotak Investment Advisors Limited managed Kotak Strategic Situations India Fund II (KSSF II) and Kotak Private Credit Fund (KPCF) have invested Rs.732 crore in the non-convertible debentures (NCDs) of RattanIndia Power Limited.
● Dr. Reddy’s Laboratories is entering into the trade generics business in India with the launch of its new division, 'RGenX'. The company will work closely with its channel partners to ensure the availability of its products.